The C-Reactive Protein/Serum Amyloid A Combined Assay Kit is a state-of-the-art diagnostic tool designed for the simultaneous detection of CRP and SAA levels in human samples. Utilizing fluorescence immunochromatography, this kit offers high sensitivity and specificity, making it an essential tool for clinical diagnostics.
1. The kit features advanced fluorescence immunochromatography technology, ensuring high accuracy and reliability in detecting CRP and SAA levels. This method allows for rapid and precise measurements, making it suitable for clinical settings.
2. The detection card is composed of anti-SAA antibodies, anti-CRP antibodies, and rabbit IgG, which are critical for the accurate detection of the target proteins. The diluent, made of Tris buffer, ensures optimal conditions for the assay.
3. This kit is primarily used for the quantitative determination of CRP and SAA in human serum, plasma, or whole blood samples. It aids in the diagnosis and monitoring of various inflammatory and infectious diseases, providing valuable insights for healthcare professionals.
The C-Reactive Protein/Serum Amyloid A Combined Assay Kit is a reliable and efficient diagnostic tool that combines advanced technology with practical applications. Its ability to simultaneously detect CRP and SAA levels makes it an invaluable resource for medical institutions.
The main features of this kit include high sensitivity, specificity, and rapid detection of CRP and SAA levels using fluorescence immunochromatography.
1. High Sensitivity: The kit is designed to detect even low levels of CRP and SAA, ensuring accurate results in clinical settings.
2. Specificity: The use of specific antibodies (anti-SAA and anti-CRP) ensures that the kit accurately targets and measures the desired proteins without cross-reactivity.
3. Rapid Detection: The fluorescence immunochromatography method allows for quick and efficient measurement of CRP and SAA levels, making it ideal for time-sensitive diagnostics.
4. User-Friendly: The kit is easy to use, with clear instructions and minimal preparation required, making it accessible for various healthcare professionals.
5. Versatility: The kit can be used with different sample types, including serum, plasma, and whole blood, providing flexibility in clinical applications.
The C-Reactive Protein/Serum Amyloid A Combined Assay Kit stands out for its high sensitivity, specificity, and rapid detection capabilities. Its user-friendly design and versatility make it a valuable tool for healthcare professionals in various clinical settings.
This kit is widely used in clinical settings for the diagnosis and monitoring of inflammatory and infectious diseases by measuring CRP and SAA levels.
1. Inflammatory Diseases: The kit is used to monitor CRP and SAA levels in patients with chronic inflammatory conditions, aiding in disease management and treatment evaluation.
2. Infectious Diseases: It helps in the early detection and monitoring of infections by measuring the levels of CRP and SAA, which are markers of acute inflammation.
3. Cardiovascular Diseases: Elevated CRP levels are associated with cardiovascular risks, and this kit assists in assessing such risks in patients.
4. Post-Surgical Monitoring: The kit is used to monitor patients post-surgery to detect any signs of infection or inflammation, ensuring timely intervention.
5. Autoimmune Diseases: It aids in the diagnosis and monitoring of autoimmune diseases by measuring CRP and SAA levels, which are often elevated in such conditions.
The C-Reactive Protein/Serum Amyloid A Combined Assay Kit is a versatile tool in clinical applications, providing valuable insights into the diagnosis and monitoring of various diseases. Its ability to measure CRP and SAA levels accurately makes it indispensable in modern healthcare.
This guide provides essential information for purchasing the C-Reactive Protein/Serum Amyloid A Combined Assay Kit, including product specifications, types, budget considerations, and usage scenarios.
1. Product Specifications: Ensure that the kit meets the required sensitivity, specificity, and accuracy standards for your clinical needs.
2. Product Types: Consider the different versions of the kit available, such as those designed for specific sample types or with additional features.
3. Budget Considerations: Evaluate the cost-effectiveness of the kit, taking into account the number of tests it can perform and its overall value in clinical settings.
4. Usage Scenarios: Assess the kit's suitability for your specific clinical applications, such as routine diagnostics, research, or specialized monitoring.
When purchasing the C-Reactive Protein/Serum Amyloid A Combined Assay Kit, it is crucial to consider product specifications, types, budget, and usage scenarios to ensure it meets your clinical requirements effectively.
Proper handling and usage of the C-Reactive Protein/Serum Amyloid A Combined Assay Kit are essential to ensure accurate results and maintain safety.
1. Storage Conditions: Store the kit at the recommended temperature to maintain the stability and effectiveness of the reagents.
2. Sample Handling: Ensure that samples are collected, stored, and processed correctly to avoid contamination or degradation.
3. Reagent Preparation: Follow the instructions carefully when preparing reagents to ensure accurate and consistent results.
4. Instrument Calibration: Regularly calibrate the instruments used with the kit to maintain accuracy and reliability.
5. Disposal: Dispose of used materials and reagents according to local regulations to ensure safety and environmental compliance.
Adhering to the recommended precautions when using the C-Reactive Protein/Serum Amyloid A Combined Assay Kit is crucial for obtaining accurate results and ensuring the safety of both users and patients. Proper storage, sample handling, and disposal practices are essential components of effective kit usage.
We have the latest medical device product database in China, which can quickly meet your procurement needs.
Submit your purchase list, and we will reply to your inquiry within half an hour at the earliest.